Collection of 295 Trichoderma isolates from Florida Myakka fine sands, representing 16 species across five clades, offering superior root colonization and biocontrol activity against soilborne pathogens like Fusarium compared to commercial temperate-derived strains. Potential application as a soil pesticide alternative for agronomic crops including tomato, watermelon, and corn.
This offering presents a diverse collection of 295 Trichoderma isolates sourced from Florida's subtropical Myakka fine sand soils, representing 16 species across five clades. These locally adapted strains have demonstrated enhanced biocontrol activity against phytopathogenic Fusarium species in laboratory assays and field trials, outperforming commercial Trichoderma isolates derived from temperate soil environments. The collection offers a promising alternative to traditional soil pesticides for improving plant health in sandy field soils, particularly for high-value agronomic crops such as tomato, watermelon, and corn.
Key features:
The Trichoderma isolate collection has progressed through multiple stages of validation. Initial screening via dual plating assays confirmed superior biocontrol activity compared to a commercial reference strain. Controlled environment studies demonstrated successful root establishment on tomato seedlings in pasteurized Myakka fine sand. Field trials have shown reduced Fusarium disease incidence over a 10-week period following soil application. Ongoing and future validation includes seedling assays with key agroeconomic crops (tomato, watermelon, corn) to assess root colonization capacity, enhanced seedling vigor, and ability to elicit plant defenses, positioning the collection for further development toward commercial deployment as a soil-applied biocontrol product.
The University of Florida is a comprehensive public research university with a broad academic and research portfolio and a statewide presence. Industry collaborates through co-located labs and shared core facilities and through an integrated academic health system that accelerates clinical translation. A statewide extension network and multiple research and education sites connect companies with field-scale testing and rapid deployment, while incubators and an adjacent innovation district provide pathways from lab to market. Research is supported by competitive funding from major federal agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office supports IP, licensing, and startup formation.